Ken Griffin Senseonics Holdings, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 184,700 shares of SENS stock, worth $86,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184,700
Previous 397,700
53.56%
Holding current value
$86,809
Previous $226,000
57.08%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SENS
# of Institutions
147Shares Held
66.2MCall Options Held
392KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA22.5MShares$10.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.9MShares$5.6 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$3.29 Million0.13% of portfolio
-
Geode Capital Management, LLC Boston, MA5.61MShares$2.64 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.09MShares$1.45 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $219M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...